Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration
Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9
Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9
Purpose: To assess the 1-year functional outcome and to evaluate the morphological changes after intravitreal injections of ranibizumab in eyes affected with retinal angiomatous proliferation (RAP) due to age-related macular degeneration (AMD).
Newsletter
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Recent Videos
Related Content
